180 results
425
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
to the Effective Time, Parent shall appoint an exchange agent (the “Exchange Agent”) to act as the agent for the purpose of paying the Merger Consideration … , including any structured finance, special purpose, or limited purpose Person, on the other hand); or (ii) any “off-balance sheet arrangements
8-K
EX-2.1
gphagr 9qtqas40tm
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-4.3
ns4s1yc dtod3bdg81h6
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.3
gkvf1uvr5hpcsv2flyi
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
wy5daxtmfu7y16t 3374
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-4.1
wmhugp674wo7nm22
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-4.2
nxqemn mn35t
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.2
98hibe
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
c3lx ann129falh
16 Sep 22
Entry into a Material Definitive Agreement
9:00am
DEF 14C
gsy02kfg
2 Jun 22
Information statement
9:15am
PRE 14C
erxcd
20 May 22
Preliminary information
9:22am
8-K
EX-10.2
050is1fo7 ak5c9wg18
3 Feb 22
Entry into a Material Definitive Agreement
5:11pm